Form D · Other Health Care

Atacama Therapeutics, Inc.

Wellesley, MA · CIK 0002022176

Offering snapshot reported May 7, 2024 · SEC filing

Reported sold
$830K
Offering amount: $4.73M
Investors reported
16
Form D · investor count
Minimum accepted
$2.5K
Reported outside-investor minimum
First sale
Apr 26, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$415K$830KMay 6, 2024: $830,000.00May 6, 2024May 7, 2024: $830,000.00May 7, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 7, 2024Amendment$830,000$0vs May 6, 202416SEC filing
May 6, 2024Initial$830,000No comparison16SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-512480

Source: Form D, filed May 7, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph Baron Director, Executive
David Dove Director
Jonathan Reis Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
65 William Street Suite 200
Wellesley, MA, 02481